Manila, Philippines, Royal Philips (NYSE: PHG, AEX: PHIA) – Asian Hospital and Medical Center’s (AHMC) recently launched its Catheterization Lab that includes the next-generation image-guided therapy platform, Philips Azurion 7 C20.
This next-generation image-guided therapy platform lets clinicians perform open and minimally invasive procedures in one room. The Azurion platform allows for easy and confident performance of a wide range of routine and complex procedures with a unique user experience, helping optimize laboratory performance and provide superior care for patients. The platform has high standards of safety and low radiation exposure that benefits both patients and staff using it.
By 2030, Asia is expected to be home to over 60% of the total population aged 65 years or older1. As the range of diseases that can be treated with minimally invasive procedures continues to expand and the procedures themselves become more efficient, the patient’s treatment experience continues to improve. They experience less trauma, and as a result, their stay in hospital can be dramatically reduced – often returning home after one night in hospital, and for some procedures even leaving the hospital on the same day.
Ashwin Chari, country manager of Philips Philippines Inc., said, “As patient volumes rise and procedures become more complex, the Philips Azurion‘s intuitive, outstanding user experience empowers doctors to have the ability to move quickly and confidently through procedures. Clinical excellence unites with workflow innovation to support clinicians in delivering outstanding patient care, reducing risk of complications and increasing operational efficiency.”